FDA Approves Rilpivirine (Edurant) for Treatment of HIV in Treatment-Naïve Patients

Hot Topics Archives

FDA Notice: Drug Interactions Between Victrelis, An HCV Protease Inhibitor, and Certain HIV Protease Inhibitors
Updated HHS Adult and Adolescent Antiretroviral Treatment Guidelines Now Available
IAPAC Guidelines on Retention and Adherence to HIV Treatment
CDC Releases 2010 HIV Surveillance Report
HIV/AIDS Clinical Education Initiative: February 2012
NQC e-Newsletter: February 2012
HEALTHQUAL Update: January 2012
HIVQUAL-US Brief: January 2012
Fenway Institute encourages all health care providers to ask patients about sexual orientation and gender identity
NYC Health Department Announces 41% Drop in HIV/AIDS Related Deaths Among Black New Yorkers
Weill Cornell accepting applications for Health Information Technology Certificate Program: Financial assistance available
CDC Releases Supplement to the 2009 HIV Surveillance Report
NQC Quality of Care Awards: Nominations Due February 29
Ryan White HIV/AIDS Program Part D Grants for Coordinated HIV Services & Access to Research for WICY: Applications due by March 16, 2012
NY HIV & AIDS Events Calendar Site: Free Event Listing Service Tool
NY & NJ AETC: Hepatitis C Treatment Update: A Self-Study Booklet
FDA Updates Tenofovir Disoproxil Fumarate (Viread) Label with New Dosing and Formulation Information
Updated CDC HIV Surveillance Slide Sets Now Available
Revised “Standards of Care” for transsexual, transgender, and gender nonconforming individuals
American Academy of Neurology Issues New Guidelines for Prescribing Antiepileptic Drugs to People Infected with HIV
HHS Guidelines Panels Issue Statement on Treating Latent Tuberculosis Infection in People Infected with HIV Receiving Antiretroviral Therapy
FDA Approves Oral Suspension Formulation of Darunavir (Prezista) and Updates Product Label
FDA Updates Ritonavir (Norvir) Label with New Safety Information
AIDS Institute’s HIV Clinical Education Initiative (CEI) Launches High-Tech Effort for HIV Education
AIDS Institute’s Voluntary HIV Provider Directory
2011 Linda Laubenstein Award Recipients
Call for Nominations: SHIN-NY Policy Committee
FDA Expands Use of Raltegravir (Isentress) to Treat HIV Infection in Children and Adolescents
NCHHSTP Releases Atlas: a new tool to create maps, charts, & tables using HIV/AIDS, Viral Hepatitis, STD, & TB surveillance data
Dear Colleague Letter: Important Information on Opioid Use Among Adolescent and Young Adults in NYS
Communications Technology in Public Health
World AIDS Day Announcement Issued by HIVMA
NYCDOHMH Health Bulletin #90: How to Prevent Pregnancy and Sexually Transmitted Infections
HAB Performance Measures: Release of Viral Load and Revised Hep B Measures
2010 NIAID Year in Review Includes Summary of HIV/AIDS Research Accomplishments
CDC Updates “HIV among Youth” Fact Sheet
Transitional Care for HIV and AIDS from Adolescence to Adulthood Webinar
HANYS Helps Providers Prepare for Launch of New York’s Medicaid Meaningful Use Program
IOM Recommends Steps to Reduce Patient Safety Risks Associated with HIT
NYS Department of Health SPNS: Job Opportunity
New Funding Available for Next Generation of Health Care Innovations
NYS Meets CDC Goal for Elimination of MTCT in 2010
FDA Updates Raltegravir (Isentress) Label with New Information on Severe Skin and Hypersensitivity Reactions
CDC HIV Mobile App Grant Opportunity Announced
AIDSinfo Health Education Materials Include Fact Sheets on HIV and Its Treatment
CDC Updates Three Fact Sheets
New Edition of AIDSinfo Glossary of HIV/AIDS-Related Terms Now Available
Women’s Health Issues Supplement Showcases Gender-Responsive National HIV/AIDS Programming for U.S. Women and Girls
FDA Launches Web Site with Information on Safe Disposal of Needles and Other Medical Sharps
HIV/AIDS Clinical Education – New Courses & Content
NQC e-Newsletter October 2011
in+care Campaign
Multiple Copies of the 6th Edition AIDSinfo Glossary Now Available
New AIDSinfo Brochure Now Available
Updated HHS Adult and Adolescent Antiretroviral Treatment Guidelines Focus on Options for Initial Therapy
NYC Health Department Promotes Testing and Awareness on National Gay Men’s HIV/AIDS Awareness Day
Fall 2011 Issue of mental health AIDS Now Available
AIDS Vaccine 2011 Post Conference Information
Updated HHS Perinatal Antiretroviral Treatment Guidelines
“Drugs That Fight HIV” Poster Features Images of Antiretroviral Medications
FDA Approves Emtricitabine/Rilpivirine/Tenofovir DF (Complera) for the Treatment of HIV in Treatment-Naive Adults
Updated HHS Pediatric Antiretroviral Treatment Guidelines
Medicaid Managed Care Enrollment: Upcoming Conference Call on the October 1, 2011 Changes
Updated HHS “Guidance for Non-HIV-Specialized Providers Caring for HIV-Infected Residents Displaced from Disaster Areas” Now Available
HIV Specialist Expert Panel Report Release
CDC Updates “HIV among Women” Fact Sheet
CDC Updates “HIV among Transgender People” Fact Sheet
Affordable Care Act Ensures Women Receive HIV Screening at No Additional Cost
CDC Publishes Statistics on Annual Number of New HIV Infections in the United States from 2006 to 2009
Research Suggests PrEP Can Reduce Risk of Acquiring HIV Infection Among Heterosexual People
NIH Announces New Funding for HIV Research
CDC Updates “Pediatric HIV Surveillance” and “HIV Surveillance in Urban and Nonurban Areas” Slide Sets
IAS 2011 Concludes
NYSDOH RFA for Physician Practice Support Program: Rolling Applications Starting June 14, 2011
June 2011 HEALTHQUAL Update
2011 All-Country Learning Network Proceedings
Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project
NYeC Digital Health Conference: Call for Speakers
HIV/AIDS Clinical Education – New CME Courses Available
AIDSinfo Health Education Series “HIV and Its Treatment” Updated
WHO HIV Guidelines on MSM and Transgender People
Summer 2011 Issue of mental health AIDS
CDC Updates Slide Sets on “HIV Surveillance in Adolescents and Young Adults” and “AIDS Trends”
FDA Approves Two New Drugs for Treatment of Chronic Hepatitis C
FDA Approves Rilpivirine (Edurant) for Treatment of HIV in Treatment-Naïve Patients
Expedited Partner Therapy (EPT) Law
NIAID Study (HPTN 052 Study) Suggests ART Reduces Risk of Transmitting HIV to Sexual Partners
CDC Updates “HIV Surveillance in Injection Drug Users” Slide Set
AIDS United Receives $1.3 Million From Elton John AIDS Foundation
Creative and Novel Ideas in HIV Research Grant Program Now Accepting Applications
amfAR Seeks Proposals to Explore HIV Persistence and Eradication
NYC Health Department Reports More than 600,000 HIV Tests Conducted Through The Bronx Knows Initiative
NYC Health Department Releases Two-Year Progress Report on City’s Take Care New York 2012 Health Agenda
Dear Colleague Letter on PrEP from the AIDS Institute
HIV Mental Health Warmline
A Public Health Approach for Advancing Sexual Health in the United States: Rationale and Options for Implementation, Final Meeting Report
HRSA Bureau of Primary Health Care Program Assistance Letter (PAL) 2011-06
HRSA Guide for HIV/AIDS Clinical Care
amfAR is Accepting Letters of Intent for the Mathilde Krim Fellows in Basic Biomedical Research Program
CDC Updates “HIV and TB” Fact Sheet
CDC Releases Extended HIV Surveillance Report
Spring 2011 Issue of mental health AIDS
Doctors Across New York (DANY) Practice Support Program: DOH RFP released
Resource to Help in Addressing HIV Among Latino Gay Men
amfAR, the Foundation for AIDS Research Announces Funding Opportunity for Latin American Grassroots Organizations
HEALTHQUAL International 2011 All-Country Learning Network (ACLN)
NQC is Accepting Nominations for the 2011 Quality of Care Awards
HHS Announces New Action Plan to Prevent, Care, and Treat Viral Hepatitis
CDC Updates “HIV Surveillance in Women” Slide Set
HUD Announces $9.1 million in HOPWA Funding
Prevention of HIV Transmission/Acquisition through a better understanding of Reproductive Health (R01) FOA
CDC Updates HIV Surveillance by Race/Ethnicity Slide Set
FDA Updates Enfuvirtide (Fuzeon) Label with New Data on Incidence of Bacterial Pneumonia
FDA approves Victrelis^TM (boceprevir) for Hepatitis C
SAMHSA accepting applications for $40.25 million for HIV/AIDS programs
Institute of Human Virology Receives $23.4 Million to Develop HIV/AIDS Vaccine
CDC Releases Supplement to the 2009 HIV Surveillance Report
New York City HIV/AIDS Surveillance Slide Sets
NYC AIDS Fund Gives $1.3 Million to Stop the Spread of HIV/AIDS and Improve Care for Those with the Disease
CDC Commemorates 30 Years of Fighting the HIV/AIDS Epidemic
Funding Opportunity: NIH/PEPFAR Collaboration for Implementation Science and Impact Evaluation (R01) – Deadline: July 7, 2011
IOM Releases Report an Important New Report About the Health of LGBT People
HHS Action Plan to Reduce Racial and Ethnic Health Disparities
Clinical Response Coordinator to Ivorian Refugee Crisis in Southeastern Liberia
amfAR Seeks Proposals for MSM Initiative Community Awards in Asia-Pacific Region – Deadline: May 4, 2011
CDC Releases Supplement to the 2009 HIV Surveillance Report
Highlights from the White House Meeting for National Women and Girls HIV/AIDS Awareness Day
Understanding Patient-Centered Care, Consumer Involvement & Patient Self-Management Brochure
IOM Releases Report on Health Care System Capacity for Increased HIV Testing and Care
Kaletra Oral Solution Label Changes Related to Toxicity in Preterm Neonates
Research on role of rectal use of personal lubricants in HIV transmission and viral replication in vivo
CDC Study – Reverse Sequence Syphilis Screening Algorithm
Recall of Triad Group Alcohol Prep Products
New York State Department of Health AIDS Institute Advisory Committee News Briefs – January 2011
Agency Operational Plans for Implementing the National HIV/AIDS Strategy
CDC’s Interim Guidance on PrEP for the Prevention of HIV Infection in Men Who Have Sex with Men
New York Statewide HIV/AIDS Training Calendar January – June 2011
Updated DHHS Adult and Adolescent Antiretroviral Treatment Guidelines Now Available
Institute of Medicine Issues Second Report on HIV Screening and Access to Care
HRSA Announcement: New Fiscal Year (FY) 2011 Grant Competition: Health Center Planning Grants (HRSA-11-021)
USDA and HHS Announce New Dietary Guidelines to Help Americans Make Healthier Food Choices and Confront Obesity Epidemic
NYC DOHMH: Teens in NYC
NYC DOHMH Takes Its Latest HIV Awareness Campaign to the Subway
VOICES 2011 Call for Abstracts – Deadline Monday, February 14
Metronidazole Tablets, 250mg: Recall – Underweight Tablets
Materials Posted for December 9, 2010 HIV Quality of Care Advisory Committee Meeting Materials
Request for Abstract Reviewers for the 2011 National HIV Prevention Conference
HIV/AIDS Clinical Education – New CME Courses
2010 CDC STD Treatment Guidelines
AIDS Alliance for Children, Youth & Families’ Open Call for Committee Nominations
Partner Services Patient’s Guide Brochure
SAMHSA: mental health AIDS, Winter 2011
Social Media: Going Viral Against HIV and STIs Webcast
Pediatric HIVQUAL-T: Measuring and Improving the Quality of Pediatric HIV Care in Thailand, 2005-2007
2010 Laubenstein Award Recipient
HHC Today: The Graying of HIV
Health Department Media Campaign Shows How HIV Can Compromise Health
Mayor Bloomberg Commemorates World AIDS Day and Launches ‘Brooklyn Knows’ Voluntary HIV Testing Initiative
CHI: Diagnosing and Managing Hepatitis C
Approval of Rapid INSTI[TM] HIV-1 Antibody Test
POZ Magazine’s December Issue Recognizes NYSDOH AIDS Institute’s Director as Part of the POZ 100
The Global Fund Approves US$1.7 Billion in New Grants
Microbicide Senior Research and Development Advisor – CAMRIS International
National AIDS Fund and AIDS Action Merge
PEP Widget for HIV Post-Exposure Prophylaxis
In Memoriam: Keith Krasinski, MD
Pre-Exposure Prophylaxis (PrEP): A Major Advance in HIV Prevention Research
NYSDOH Articles on Success in Reduction of Mother-To-Child Transmission of HIV
HEALTHQUAL Brief on Quality Improvement and Tuberculosis, Issue III & IV
Get Vital Information on HIV Testing
Objective for Healthy People 2020 Includes LGBT Health
New York State HIV Testing Law, Changes Effective September 1, 2010
All-Country Learning Network 2010 Proceedings
Improving the Management of HIV Disease Web-Based CME Conference
Internet-Based Personal Health Records Helpful to Most HIV/AIDS Patients Who Used Them
NYSDOH AIDS Institute: 25 Years of Leadership, Service and Compassion
New York State HIV Quality of Care Program is Accepting Nominations for the 2010 Quality Improvement Awards
CDC Offers Post-Doctoral Research Fellowships for HIV Prevention in Communities of Color
New CDC HIV Surveillance Slides Available
NY State Health Department Success in Reducing Mother-to-Child HIV Transmission Highlighted in Public Health Journal
HEALTHQUAL Brief on Quality Improvement and Tuberculosis, Issue II
Harm Reduction Coalition Now Has a Weekly Podcast
Materials Posted for September 16, 2010 HIV Quality of Care Advisory Committee Meeting
NASTAD Statement of Urgency – HIV and STD Crisis Among Gay Men
Red Ribbon, Silver Threads: Healthy Aging with HIV/AIDS
City Health Information: Treating Tobacco Addiction
NYSDOH-OASAS Health Advisory: Levamisole-Contaminated Cocaine
City Health Information: HIV Prevention and Care
New York State Health Commissioner Warns: HIV/AIDS Not Just a Threat to Young People
HEALTHQUAL Brief on Quality Improvement and Tuberculosis
Guide to HIV/AIDS in Faith Communities
Collaboration of the Clinical Education Initiative (CEI) and Physicians’ Research Network (PRN)
New Clinical Education Initiative (CEI) CME Courses
2009/2010 Dental Resource Directory to Improve Access to Dental Care for People Living with HIV/AIDS in New York
Governor Paterson Signs Bills to Promote HIV Testing and Remove Barriers to Needle Exchange and Syringe Access
HIV Clinical Guidelines Program Posters at XVIII International AIDS Conference
Partner Services for HIV Prevention
Tenofovir Gel Used Before and After Sex Reduced HIV by 39 Percent
Materials Posted for June 10, 2010 HIV Quality of Care Advisory Committee Meeting
Possible Levamisole-Induced Toxicity in Cocaine-Using Patients in New York
75% of New Yorkers Living with HIV/AIDS Are 40 or Older and More than a Third Are over 50
National HIV/AIDS Strategy
Bronx Residents Have Received More Than 375,000 HIV Tests Since 2008
FDA Approves Maraviroc Labeling Changes
CDC Health Advisory – Potential Contaminated IV Bags
Dear Colleague letter – “RU+” Campaign from NYSDOH AIDS Institute
HIV and H1N1 Information
Free HIV CME Courses
Earlier Initiation of ARV Therapy? An Appraisal of Emerging Data
New York State Health Department Launches Media Campaign on AIDS Stigma
Guiding Principles for Sexual Health Education for Young People
NYCDOHMH: Health Bulletin – Stop HIV in NYC
Ryan White Clinical Updates Online
2010 CROI Summary from Dr John Bartlett
Printed edition of Substance Use Clinical Guidelines book is now available
First Assay to Detect Both HIV Antigen and Antibodies
ONAP Report: Community Recommendations for National HIV/AIDS Strategy
The Barbara H Chaffee, MD, MPH Educational Fund
RU+? Get an HIV Test — Poster
Dr John Bartlett Literature Reviews
“RU+” Campaign on YouTube – Take the Time. Take the Test. Take Charge.
The HIV Research Catalyst Forum: Treatment, Prevention, Advocacy
Governor Paterson Praises Appointment of AIDS Institute Director to Presidential Advisory Council on HIV/AIDS
FDA Reviews Osteoporosis Drugs
Medical Volunteers Needed in Haiti
Ryan White Tribute
Follow Us on Twitter, Facebook, and LinkedIn
New York State HIV/AIDS Training Calendar 2010
2009 Resource Directory for the AIDS Institute
Additions from the AIDS Institute to the New York State Department of Health Website
CHI: HIV Prevention and Care
2010 IDSA ERF Medical Scholars Program
United Hospital Fund – Health Care Improvement Grant
New Manual to Help Safety Net Providers Qualify as Patient-Centered Medical Homes
Letter from the AIDS Institute about Novel H1N1 Influenza and HIV
Counseling Messages for the Survivor of Felony Sexual Assault
HIV Testing of Defendants of Felony Sexual Assault webcast
CDC.gov: Issues with Oral Fluid Rapid Tests
NYS Court-Ordered HIV Testing of Defendants
Dear Colleague Letter: False-Positive Results with Use of Oral Fluid Rapid Test
Health Alert: Treatment for Fluoroquinolone-resistant (QRNG) Gonorrhea

We want your feedback!

May 2011

The FDA approved Edurant (rilpivirine) 25 mg tablets, a new non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. Rilpivirine is an antiviral drug that helps to block reverse transcriptase, an enzyme necessary for HIV replication. The recommended dose of rilpivirine is one 25 mg tablet once daily taken orally with a meal.

Prescribing information for Edurant is available at:

http://www.tibotectherapeutics.com/sites/default/files/downloads/pdf/EDURANT-PI.pdf